Q4 2024 Management View CEO David Loew emphasized Ipsen’s sustained growth in 2024, with total sales increasing by 9.9%. He highlighted the strong performance of the ex-Somatuline portfolio, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback